227 related articles for article (PubMed ID: 23542580)
1. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.
Habibi J; Whaley-Connell A; Qazi MA; Hayden MR; Cooper SA; Tramontano A; Thyfault J; Stump C; Ferrario C; Muniyappa R; Sowers JR
Endocrinology; 2007 May; 148(5):2181-8. PubMed ID: 17317778
[TBL] [Abstract][Full Text] [Related]
3. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
[TBL] [Abstract][Full Text] [Related]
4. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.
Xu H; Yang YJ; Qian HY; Tang YD; Wang H; Zhang Q
Circ J; 2011; 75(6):1476-85. PubMed ID: 21502705
[TBL] [Abstract][Full Text] [Related]
6. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis.
Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X
Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829
[TBL] [Abstract][Full Text] [Related]
7. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy.
Nam HK; Lee SJ; Kim MH; Rho JH; Son YK; Lee SM; Kim SE; Kim KH; An WS
Am J Nephrol; 2013; 37(1):7-15. PubMed ID: 23258196
[TBL] [Abstract][Full Text] [Related]
9. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
[TBL] [Abstract][Full Text] [Related]
11. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Ma YX; Li WH; Xie Q
Pharmazie; 2013 May; 68(5):355-8. PubMed ID: 23802433
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
Xu X; Zhang L; Liang J
Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.
Yang Y; Mou Y; Hu SJ; Fu M
Eur J Heart Fail; 2009 Jan; 11(1):6-13. PubMed ID: 19147451
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin inhibits pressure-induced fibrotic responses via the expression regulation of prostacyclin and prostaglandin E2 in rat renal tubular cells.
Chen CH; Cheng CY; Chen YC; Sue YM; Hsu YH; Tsai WL; Chen TH
Eur J Pharmacol; 2013 Jan; 700(1-3):65-73. PubMed ID: 23276663
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]